Since the first case of AIDS was reported in 1981, researchers have been trying to develop treatments to help keep the HIV virus at bay. One of the newest techniques, resistance testing, may help to increase success rates even more.
To date, the most effective treatment for HIV is highly active antiretroviral therapy, more commonly known as HAART. This combination of medications is used to fight the various forms of HIV that may be present in your body. When taken regularly, HAART lowers the amount of virus to a level where it can no longer attack your body in a significant way.
Astoundingly, up to 10 billion new HIV viruses are produced daily inside an infected person. Of these, 10 million will be produced that have a mutation, or error, in their genetic code. While most of these errors will be fatal to the virus, a few resistant forms may be created which can outmaneuver traditional HAART treatment.
Traditionally, resistance is detected indirectly: If the amount of HIV in the blood fails to drop after beginning HAART, doctors may switch to other drug combinations to try to keep the virus in check. Finding resistance before treatment even begins, however, can help speed treatment, lower drug costs and prevent damage to the body.
That's where HIV resistance testing comes in. This test provides doctors and patients a picture of the mixture of HIV mutations present in a patient's body.
"There is an advantage of doing drug resistance testing as soon as possible," says Rowena Johnston, PhD, director of basic research at The American Foundation for AIDS Research (amfAR). "It will inform treatment decisions, even if those decisions don't come until years and years down the line."